UP Campus: Mexico City

  • Bachelor's Degree in Administration and Finance

    Bachelor's Degree in Administration and Finance

    Bachelor's Degree in Administration and Finance

  • Gregorio Tomás Obrador Vera

    Gregorio Tomás Obrador Vera

    Dr. Gregorio Tomás Obrador Vera studied medicine at the Autonomous University of San Luis Potosí and the School of Medicine at the University of Navarra in Spain. He completed his residency in internal medicine at the National Institute of Medical Sciences and Nutrition and at Western Pennsylvania Hospital in Pittsburgh, where he served as chief resident. He subsequently completed a subspecialty fellowship in nephrology at Boston University, an advanced clinical research program at Tufts-New England Medical Center, and a master’s degree in public health at Harvard University.

    He joined the School of Medicine at the National Autonomous University of Mexico ( Universidad Panamericana ) in 1998 as coordinator of clinical sciences and, one year later, as associate academic director. He served as dean of the School of Medicine (2005–2022) and of the Faculty of Health Sciences (2012–2022). Since 2023, he has served as Director General of Health at the National Institute of Public Health ( Universidad Panamericana).

    In addition to his clinical and teaching activities as a Full Professor of Nephrology, he is a Senior Researcher (Level D) at the Universidad Panamericana. He also holds an appointment as Adjunct Assistant Professor of Medicine at Tufts University School of Medicine in Boston.

    His research focuses on nephrology and, in particular, chronic kidney disease. He has received several awards and honors and has served on numerous national and international committees, including the Executive Committee of Kidney Disease: Improving Global Outcomes (KDIGO), the External Expert Panel of the United States Renal Data System (USRDS), the WHO Network on Noncommunicable Diseases (NCDNet), and the Clinical Research Program for Latin America of the International Society of Nephrology. He has also served as principal investigator, regional lead, and steering committee member in several multicenter clinical trials, such as the CREDENCE and ASCEND studies.

    He served as president of the Mexican Council of Nephrology and is currently president-elect of the Mexican Institute of Nephrological Research, as well as a full member of the National Academy of Medicine of Mexico.

    He has authored numerous publications and has delivered more than 315 lectures at national and international forums.

    • Epidemiology and Early Detection of Chronic Kidney Disease
    • A Multidisciplinary Model of Care for Chronic Kidney Disease
    • Anemia Associated with Chronic Kidney Disease
    • Palliative and Supportive Care for Kidney Patients
    • Clinical Practice Guidelines
    • Clinical Trials
  • Guadalupe Janette Furuzawa Carballeda

    Guadalupe Janette Furuzawa Carballeda

    Dr. Guadalupe Janette Furuzawa Carballeda is a pharmaceutical chemist and biologist specializing in biochemistry and microbiology. She graduated from the School of Chemistry at the National Autonomous University of Mexico (UNAM). She earned a master’s degree in Basic Biomedical Research in Immunology and a Ph.D. in Cell Biology from the Institute of Biomedical Research at UNAM.

    Since 2001, she has served as a Level D Medical Sciences Researcher at the Salvador Zubirán National Institute of Medical Sciences and Nutrition, where she has conducted ongoing scientific research and participated in various collaborative research projects. Since May 2021, she has been a Level D research professor in the School of Health Sciences at the Universidad Panamericana. She is classified as Level 3 in the SNII.

    Throughout her more than 30-year career, Dr. Furuzawa Carballeda has made fundamental contributions to the study of the mechanisms of inflammation, immune regulation, and autoimmunity, notably through the development of clinically effective modified extracellular matrix molecules for the modulation of inflammatory processes. This innovative work has resulted in 21 national and international patents.

    It has developed a drug based on collagen-polyvinylpyrrolidone that modulates chronic joint inflammation, enabling the safe and effective modification of the progression of osteoarthritis, one of the leading chronic degenerative diseases. The corresponding clinical studies have a level of evidence of 1a (IMSS Clinical Practice Guideline 32910), which has allowed for its inclusion in the Basic Health Sector List (Group N20; codes 00.000.3999.00 and 010.000.3999.01).

    His academic output includes more than 100 scientific publications indexed in PubMed, book chapters, and presentations at national and international conferences. He has received numerous awards, including the National Chamber of the Pharmaceutical Industry (CANIFARMA) Award in 2006, 2022, and 2023; the “Dr. Roberto Kretschmer Schmid” Award from the National Academy of Medicine in 2011, 2014, and 2017; and the “Eduardo Liceaga” Award in 2020.

    Finally, his commitment to training professionals stands out, as he has contributed to the academic education of undergraduate students and at least 18 graduate and specialty students, as well as medical interns.

    • Identification of the mechanisms underlying inflammation (Th17, Th22, and Th9), immune regulation (Tregs, Bregs, and pDCregs), and autoimmunity
    • Development of clinically effective modified extracellular matrix molecules for the modulation of inflammatory processes (rheumatoid arthritis and osteoarthritis)
    • Assessment of Peripheral Tolerance in Autoimmune Diseases
    • Evaluation of the pathophysiological mechanisms (genotyping, immunophenotyping, proteomics, etc.) of achalasia
  • Business School Alumni Breakfast

    Business School Alumni Breakfast

    Let’s celebrate our graduation anniversaries together!
    There are bonds that last a lifetime and moments worth celebrating again.
    The School of Business at the University of Buenos Aires ( Universidad Panamericana ) invites its alumni to reunite and celebrate 5, 10, 15, 20, 25, 30, 35, 40, and 45 years since graduation.
    A morning to reminisce about our college days, reconnect with classmates and professors, share experiences, and continue strengthening the bonds that tie us to our alma mater.

  • Mechatronics Engineering

    Mechatronics Engineering

    Mechatronics Engineering

  • Mechanical Engineering Program

    Mechanical Engineering Program

    Mechanical Engineering Program

  • Industrial Engineering and Data Driven Innovation

    Industrial Engineering and Data Driven Innovation

    Industrial Engineering and Data Driven Innovation

  • Data Intelligence and Cybersecurity Engineering

    Data Intelligence and Cybersecurity Engineering

    Data Intelligence and Cybersecurity Engineering

  • Innovation and Design Engineering

    Innovation and Design Engineering

    Innovation and Design Engineering

  • Animation and Videogaming Engineering Program

    Animation and Videogaming Engineering Program

    Animation and Videogaming Engineering Program

    Animation and Videogaming Engineering Program

  • Law Program

    Law Program

    Law Program